These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26080829)

  • 1. Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.
    Zhu H; Yun F; Shi X; Wang D
    Int J Mol Med; 2015 Aug; 36(2):595-601. PubMed ID: 26080829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Zhu H; Yun F; Shi X; Wang D
    Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
    J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane inhibits the proliferation of the BIU87 bladder cancer cell line via IGFBP-3 elevation.
    Dang YM; Huang G; Chen YR; Dang ZF; Chen C; Liu FL; Guo YF; Xie XD
    Asian Pac J Cancer Prev; 2014; 15(4):1517-20. PubMed ID: 24641360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
    Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
    Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell cycle arrest and apoptosis by grape seed procyanidin extract in human bladder cancer BIU87 cells.
    Liu J; Zhang WY; Kong ZH; Ding DG
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3282-91. PubMed ID: 27467005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
    Lee S; Yoon CY; Byun SS; Lee E; Lee SE
    J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
    Liu X; Liu X; Wu Y; Fang Z; Wu Q; Wu C; Hao Y; Yang X; Zhao J; Li J; Wang Q; Yang Z; Xu J; Hu X; Tan M; Li L
    Cell Physiol Biochem; 2018; 48(1):87-98. PubMed ID: 30001529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway.
    Bu Q; Fang Y; Cao Y; Chen Q; Liu Y
    Mol Med Rep; 2014 Oct; 10(4):2203-9. PubMed ID: 25109742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
    Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
    Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antisense RNA of survivin gene enhances the taxol-induced apoptosis and sensitivity to chemotherapy drugs in bladder cancer cells: an in vitro experiment].
    Wang ZH; Ye Q; Huang DY; Hu ZQ; Ye ZQ; Yang N; Liu H; Zhuang QY; Yang WM; Liu JH; Zhang X
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):419-22. PubMed ID: 17456386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
    Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
    Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
    Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M
    Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
    Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5‑bromo‑3‑(3‑hydroxyprop‑1‑ynyl)‑2H‑pyran‑2‑one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways.
    Yu GQ; Dou ZL; Jia ZH
    Mol Med Rep; 2017 Jan; 15(1):153-159. PubMed ID: 27922685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of PTEN gene transfection on proliferation and invasion of human bladder cancer cell line BIU87].
    Zhang JH; Yang WM; Zhou SW; Chen Z
    Ai Zheng; 2006 May; 25(5):555-9. PubMed ID: 16687073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells.
    Li X; Chen D; Yin S; Meng Y; Yang H; Landis-Piwowar KR; Li Y; Sarkar FH; Reddy GP; Dou QP; Sheng S
    J Cell Physiol; 2007 Aug; 212(2):298-306. PubMed ID: 17458898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.
    Miyake H; Hara I; Yamanaka K; Muramaki M; Gleave M; Eto H
    Oncol Rep; 2005 Feb; 13(2):341-5. PubMed ID: 15643522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
    Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
    Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.